4Filing Date: Mar 12, 2026

Gilead (GILD)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001927648-26-000002
Total Value$0
Trades2
Insiders1

Transaction Details

Burkhart Erin
SVP, Controllership·Direct
Grant · Acquire
Non-qualified Stock Option (Right to Buy)Derivative
Shares+5.46K
Price$0.00
Total Value$0
Shares Owned After5.46K
Transaction DateMar 10, 2026
ExpiresMar 10, 2036
Footnotes ▸

The stock options have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.

Burkhart Erin
SVP, Controllership·Direct
Grant · Acquire
Restricted Stock UnitDerivative
Shares+2.35K
Price-
Total Value$0
Shares Owned After11.24K
Transaction DateMar 10, 2026
Footnotes ▸

Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. | The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.

Post-Transaction Holdings

Burkhart Erin · SVP, Controllership
SecuritySharesChange
Non-qualified Stock Option (Right to Buy)5.46K+5.46K
Restricted Stock Unit11.24K+2.35K (26.49%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-03-10 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: GILEAD SCIENCES, INC. (GILD) CIK: 0000882095 --- Reporting Owner --- Name: Burkhart Erin CIK: 0001927648 Role: Officer (SVP, Controllership) --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Unit Date: 2026-03-10 | Code: A (Grant or award) Shares: +2,355 Shares Owned After: 11,245 | Ownership: D (Direct) Footnotes: [F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. [F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. [F2] The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. [F2] The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. [Transaction #2] Security: Non-qualified Stock Option (Right to Buy) Date: 2026-03-10 | Code: A (Grant or award) Shares: +5,455 | Price: $0.00 Exercisable: N/A | Expires: 2036-03-10 Shares Owned After: 5,455 | Ownership: D (Direct) Footnotes: [F3] The stock options have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. --- Footnotes (Complete Index) --- F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2: The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. F3: The stock options have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. --- Signature --- /s/ /s/ Amy Kim by Power of Attorney for Erin E. Burkhart (2026-03-12)

keid analysis is for reference only and does not constitute investment advice.